European Commission Approves Bavencio (Avelumab) for Metastatic Merkel Cell Carcinoma September 21, 2017October 21, 2019 by / Share This.....LinkedinTwitterFacebookGoogleEmailDownload PDF Related News: European Commission approves Roche’s Gavreto…European Commission approves Roche’s Tecentriq as…European Commission approves Roche’s first-in-class…European Commission approves Roche’s Vabysmo, the…European Commission approves label expansion of…European Commission approves Roche’s Tecentriq SC,…
